Solid pseudopapillary tumour of the pancreas

CHIMERA: A Phase II Study of Neoadjuvant Pembrolizumab in Combination With Cisplatin or Carboplatin and Pemetrexed Followed by Surgery and Adjuvant Pembrolizumab in Resectable Pleural Mesothelioma.

Clinical lung cancer·2026

Cost-effectiveness analysis of lorlatinib as first-line treatment for anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer in Italy.

Journal of medical economics·2026

Lorlatinib in patients with ALK-positive metastatic NSCLC previously treated with an ALK inhibitor: results from a phase IV study.

Future oncology (London, England)·2026

Fulzerasib plus cetuximab in first-line KRASG12C-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial.

The Lancet. Oncology·2026

BRAF class II-III mutations in NSCLC: a single center experience.

Frontiers in oncology·2026

Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib.

Clinical lung cancer·2026

Local management of second ipsilateral breast cancer events after primary breast-conserving therapy: an international Delphi consensus.

The Lancet. Oncology·2026

Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research.

The Lancet. Oncology·2026

Advancing oncology education in low-income and middle-income African settings: global insights for local action.

The Lancet. Oncology·2026

Intravesical cretostimogene grenadenorepvec oncolytic immunotherapy in high-risk, BCG-unresponsive, non-muscle-invasive bladder cancer with carcinoma in situ (BOND-003 Cohort C): a single-arm, phase 3 trial.

The Lancet. Oncology·2026

Postmastectomy chest wall radiotherapy for breast cancer (SUPREMO): 5-year quality-of-life results from a randomised, controlled, phase 3 trial.

The Lancet. Oncology·2026

Addition of irinotecan to chemoradiotherapy as preoperative treatment for locally advanced rectal cancer (ARISTOTLE): a multicentre, open-label, phase 3, randomised controlled trial.

The Lancet. Oncology·2026

Self-determination and plasma donation: The role of autonomous motivation.

Journal of health psychology·2026

Is Prevena a better choice for patients with pressure ulcers after reconstruction?

Journal of wound care·2026

Interaction of Strong Electromagnetic Waves with Unmagnetized Pair Plasmas.

Physical review letters·2026

How Zonal Fields Suppress Reversed Shear Alfvén Eigenmode in Tokamak Plasmas.

Physical review letters·2026

Impact of nonthermal plasma on the nutritional and phenolic bioaccessibility characteristics of wheat bran.

Food chemistry·2026

Record-high room-temperature K+ ionic conductivity in anion-deficient pyrochlore.

Chemical communications (Cambridge, England)·2026

Related Experiment Videos

Solid pseudopapillary tumour of the pancreas

Related Concept Videos

CHIMERA: A Phase II Study of Neoadjuvant Pembrolizumab in Combination With Cisplatin or Carboplatin and Pemetrexed Followed by Surgery and Adjuvant Pembrolizumab in Resectable Pleural Mesothelioma.

Cost-effectiveness analysis of lorlatinib as first-line treatment for anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer in Italy.

Lorlatinib in patients with ALK-positive metastatic NSCLC previously treated with an ALK inhibitor: results from a phase IV study.

Fulzerasib plus cetuximab in first-line KRASG12C-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial.

BRAF class II-III mutations in NSCLC: a single center experience.

Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib.

Local management of second ipsilateral breast cancer events after primary breast-conserving therapy: an international Delphi consensus.

Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research.

Advancing oncology education in low-income and middle-income African settings: global insights for local action.

Intravesical cretostimogene grenadenorepvec oncolytic immunotherapy in high-risk, BCG-unresponsive, non-muscle-invasive bladder cancer with carcinoma in situ (BOND-003 Cohort C): a single-arm, phase 3 trial.

Postmastectomy chest wall radiotherapy for breast cancer (SUPREMO): 5-year quality-of-life results from a randomised, controlled, phase 3 trial.

Addition of irinotecan to chemoradiotherapy as preoperative treatment for locally advanced rectal cancer (ARISTOTLE): a multicentre, open-label, phase 3, randomised controlled trial.

Self-determination and plasma donation: The role of autonomous motivation.

Is Prevena a better choice for patients with pressure ulcers after reconstruction?

Interaction of Strong Electromagnetic Waves with Unmagnetized Pair Plasmas.

How Zonal Fields Suppress Reversed Shear Alfvén Eigenmode in Tokamak Plasmas.

Impact of nonthermal plasma on the nutritional and phenolic bioaccessibility characteristics of wheat bran.

Record-high room-temperature K+ ionic conductivity in anion-deficient pyrochlore.

Related Experiment Videos

Solid pseudopapillary tumour of the pancreas

Related Concept Videos

Related Articles